Indication
Central Retinal Artery Occlusion
3 clinical trials
5 products
Product
KUS121Clinical trial
A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)Status: Recruiting, Estimated PCD: 2024-12-01
Product
Sham procedureClinical trial
Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery OcclusionStatus: Recruiting, Estimated PCD: 2026-12-31
Product
AlteplaseClinical trial
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.Status: Recruiting, Estimated PCD: 2024-10-28
Product
TenecteplaseProduct
Acetylsalicylic Acid